Downstream Processing Featured Articles
-
Bio/Pharma Industry Improves Downstream Operations
Best Practices: Membrane Technology Options
-
3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products
5/4/2012
3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules. The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.
-
Repligen Acquires Bioprocessing Business Of Refine Technology
6/3/2014
Repligen Corporation announced recently that it has acquired the business of Refine Technology (“Refine”), including Refine’s Alternating Tangential Flow (“ATF”) System, a market-leading device used to significantly increase product yield during the fermentation step of the biologic drug manufacturing process.
-
Designer Bacteria May Lead To Better Vaccines
1/15/2013
Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
-
Single-Use Tubing And Filter/Tubing Assemblies
4/27/2011
Meissner’s BioFlex™ fluid path assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications. These single-use tubing and filter/tubing assemblies offer maximum convenience and flexibility in single-use systems.
-
Getting A Biotech Back On The Path Toward Commercialization
3/28/2012
There has been much debate as to how much it costs to get a new drug from discovery to market — anywhere from Light and Waburton’s 2011 estimate of R&D costs being in the neighborhood of $59.4M to PhRMA’s mind-numbing figure of $1.32B. By Rob Wright
-
Oncobiologics, Inc. Announces A Collaboration Agreement With XOMA Corporation To Utilize XOMA’s Fully Human Antibody Libraries For Their Discovery Platform
7/30/2012
Oncobiologics, Inc. announced recently a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering single-chain variable fragments (scFv) into a bi-specific antibody scaffold.
-
Complete 400,000 Sq. Ft. Pharmaceutical Facility Auction Announced For May 9 & 10
4/3/2012
A Huge 2-Day Live Onsite and Webcast Auction of Complete 400,000 Sq. Ft. Late Model Tablet, Capsule, Solution, Cream and Lotion Processing and Packaging Facility.
-
Roche Receives FDA Clearance For Herpes Simplex Virus Type 1 And 2 Tests
9/4/2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection.
-
Hamilton Robotics Launches Highly Flexible PCR Setup Workstation
3/18/2013
Hamilton Robotics introduces the PCR setup STARlet, the first automated liquid handling system flexible enough to accommodate any DNA amplification reagent kit, from simple setups and small budgets to highly demanding workflows.